Literature DB >> 21700307

The adenovirus E4 11 k protein binds and relocalizes the cytoplasmic P-body component Ddx6 to aggresomes.

Amy E Greer1, Patrick Hearing, Gary Ketner.   

Abstract

The adenovirus E4 11 k protein, product of E4 ORF3, is required in infection for processes including normal accumulation of viral late mRNAs. 11 k restructures both the nucleus and cytoplasm of infected cells by relocalizing specific host cell target proteins, most strikingly components of nuclear PML oncogenic domains. It is likely that in many cases relocalization inactivates target proteins to produce 11 k's effects, although the mechanism and targets for stimulation of late mRNA accumulation is unknown. We have identified a new set of proteins relocalized by 11 k: at least five protein components of cytoplasmic mRNA processing bodies (p-bodies) are found in 11 k-induced cytoplasmic aggresomes, sites where proteins are inactivated or destroyed. One of these p-body proteins, RNA helicase Ddx6, binds 11 k, suggesting a mechanism for relocalization. Because p-bodies are sites for mRNA degradation, their modification by 11 k may provide an explanation for the role of 11 in viral late mRNA accumulation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700307      PMCID: PMC3152696          DOI: 10.1016/j.virol.2011.05.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

Review 1.  DEAD-box proteins: the driving forces behind RNA metabolism.

Authors:  Sanda Rocak; Patrick Linder
Journal:  Nat Rev Mol Cell Biol       Date:  2004-03       Impact factor: 94.444

2.  Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.

Authors:  Amy Baker; Kent J Rohleder; Les A Hanakahi; Gary Ketner
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 3.  Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design?

Authors:  Thomas Wileman
Journal:  Annu Rev Microbiol       Date:  2007       Impact factor: 15.500

4.  The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.

Authors:  Mark A Yondola; Patrick Hearing
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

5.  Adenovirus early region 4 is essential for normal stability of late nuclear RNAs.

Authors:  A B Sandler; G Ketner
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

8.  Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response.

Authors:  Amanda J Ullman; Nancy C Reich; Patrick Hearing
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

9.  Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies.

Authors:  A Zantema; J A Fransen; A Davis-Olivier; F C Ramaekers; G P Vooijs; B DeLeys; A J Van der Eb
Journal:  Virology       Date:  1985-04-15       Impact factor: 3.616

10.  Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54.

Authors:  Chia-ying Chu; Tariq M Rana
Journal:  PLoS Biol       Date:  2006-07       Impact factor: 8.029

View more
  12 in total

1.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

2.  Manipulation of cellular processing bodies and their constituents by viruses.

Authors:  Asit K Pattnaik; Phat X Dinh
Journal:  DNA Cell Biol       Date:  2013-04-25       Impact factor: 3.311

3.  DDX6 localizes to nuage structures and the annulus of mammalian spermatogenic cells.

Authors:  Chika Kawahara; Sadaki Yokota; Hideaki Fujita
Journal:  Histochem Cell Biol       Date:  2013-10-20       Impact factor: 4.304

Review 4.  Diversion of stress granules and P-bodies during viral infection.

Authors:  Lucas C Reineke; Richard E Lloyd
Journal:  Virology       Date:  2013-01-03       Impact factor: 3.616

5.  Determination of host RNA helicases activity in viral replication.

Authors:  Amit Sharma; Kathleen Boris-Lawrie
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 6.  Viral Regulation of RNA Granules in Infected Cells.

Authors:  Qiang Zhang; Nishi R Sharma; Zhi-Ming Zheng; Mingzhou Chen
Journal:  Virol Sin       Date:  2019-04-29       Impact factor: 4.327

Review 7.  Strategies for Success. Viral Infections and Membraneless Organelles.

Authors:  Aracelly Gaete-Argel; Chantal L Márquez; Gonzalo P Barriga; Ricardo Soto-Rifo; Fernando Valiente-Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2019-10-11       Impact factor: 5.293

8.  Adenoviral vectors stimulate glucagon transcription in human mesenchymal stem cells expressing pancreatic transcription factors.

Authors:  Arnaud Zaldumbide; Françoise Carlotti; Manuel A Gonçalves; Shoshan Knaän-Shanzer; Steve J Cramer; Bart O Roep; Emmanuel J H J Wiertz; Rob C Hoeben
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

9.  Characterization of aggregate/aggresome structures formed by polyhedrin of Bombyx mori nucleopolyhedrovirus.

Authors:  Zhong-Jian Guo; Liu-Xing Tao; Xian-Yun Dong; Meng-Han Yu; Ting Tian; Xu-Dong Tang
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

Review 10.  Who Regulates Whom? An Overview of RNA Granules and Viral Infections.

Authors:  Natalia Poblete-Durán; Yara Prades-Pérez; Jorge Vera-Otarola; Ricardo Soto-Rifo; Fernando Valiente-Echeverría
Journal:  Viruses       Date:  2016-06-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.